Integrating Functional Marrow Reserve and Molecular Risk Improves Prediction of Post-Transplant Outcomes in MDSLuis E. Aguirre, Rami S. Komrokji, Amar H. Kelkar et al.|Blood Neoplasia|2026Cited by 0
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review studyJacqueline S. Garcia, Aaron D. Goldberg, P Desai et al.|Leukemia & lymphoma/Leukemia and lymphoma|2026Cited by 0